Basics United Therapeutics Corporation United Therapeutics Corp is engaged in the healthcare sector. Its core offering includes pharmaceutical products to address unmet medical needs of patients. IPO Date: June 17, 1999 Sector: Healthcare Industry: Biotech Market Cap: $21.07B Activated in VL: True Average Daily Range Avg Daily Range: $1.67 | 1.39% Avg Daily Range (30 D): $6.11 | 1.36% Avg Daily Range (90 D): $6.17 | 1.54% Institutional Daily Volume Avg Daily Volume: .52M Avg Daily Volume (30 D): .4M Avg Daily Volume (90 D): .58M Trade Size Avg Trade Size (Sh.): 87 Avg Trade Size (Sh.) (30 D): 23 Avg Trade Size (Sh.) (90 D): 32 Institutional Trades Total Inst.Trades: 14,323 Avg Inst. Trade: $5.02M Avg Inst. Trade (30 D): $20.56M Avg Inst. Trade (90 D): $25.79M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $9.6M Avg Closing Trade (30 D): $32.97M Avg Closing Trade (90 D): $39.98M Avg Closing Volume: 58.8K     News Oct 26, 2025 @ 10:31 PM Nepsis Liquidates $14 Million CyberArk Software (N... Source: Josh Kohn-Lindquist Oct 17, 2025 @ 2:00 PM Artificial Lung Market to Grow at 10.84% CAGR, Hit... Source: Towards Healthcare Sep 11, 2025 @ 3:12 PM 3 High-Growth Stocks Poised to Extend Gains Into Y... Source: Damian Nowiszewski Aug 6, 2025 @ 2:26 PM MannKind (MNKD) Q2 Revenue Rises 6% Source: Jesterai Jul 28, 2025 @ 6:48 PM ROSEN, A LEADING LAW FIRM, Encourages 3D Systems C... Source: Rosen Law Firm Financials   TTM Q2 2025 Q1 2025 Basic EPS $27.68 $6.86 $7.18 Diluted EPS $25.64 $6.41 $6.63 Revenue $ 3.08B $ 798.6M $ 794.4M Gross Profit $ 2.74B $ 711M $ 701.9M Net Income / Loss $ 1.24B $ 309.5M $ 322.2M Operating Income / Loss $ 1.45B $ 364.5M $ 382.8M Cost of Revenue $ 339.1M $ 87.6M $ 92.5M Net Cash Flow $ 237.4M $ -306.8M $ 202.7M PE Ratio 18.66     Splits Sep 23, 2009:   2:1